FDA clears Kallisio’s 3D-printed oral insert for radiation therapy

January 22, 2024
3:10 pm

Kallisio recently announced that the FDA has cleared its 3D-printed Stentra, used to protect head and neck cancer patient’s healthy tissue during radiation therapy.

Stentra is fabricated of bio-compatible nylon materials (nylon ISO 10993-1), using 3D SLS printing technology.

Baltimore-based Kallisio says Stentra directs radiation to the target tumor area while reducing the harmful impact on surrounding tissue. It also immobilizes the tongue, lips, and other at-risk organs.

Stentra fabrication takes place in less than five days.

FDA clears Kallisio’s 3D-printed oral insert for radiation therapy

Sign up for Blog Updates